在BRCA1和BRCA2序列变异的妇女中,双边卵巢切除和全因死亡率
Joanne Kotsopoulos1,2, Jacek Gronwald3, Tomasz Huzarski3
1Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
JAMA oncology
|February 29, 2024
概括
预防性卵巢切除术显著降低了BRCA1或BRCA2基因突变的妇女的全因死亡率. 这种手术干预为高危人群提供了显著的生存益处.
科学领域:
- 妇科瘤学 妇科瘤学
- 遗传学 遗传学 是一个
- 预防医学 预防医学
背景情况:
- 建议在BRCA1/2携带者身上进行预防性双边沙卵巢切除术,以减少卵巢癌的风险.
- 这种手术对这一群体的整体死亡率的影响仍然不完全理解.
研究的目的:
- 研究双边卵巢切除术与 BRCA1 或 BRCA2 序列变异的女性全因死亡率之间的关联.
主要方法:
- 在4332名BRCA1/2变异女性中进行的国际纵向队列研究.
- 双边卵巢切除术状态是通过两年一次的问卷自我报告的.
- 考克斯比例危险回归分析了所有原因的死亡率,调整年龄.
主要成果:
- 卵巢切除术在67.8%的女性中进行,平均年龄为45.4岁.
- 观察到所有原因死亡率显著降低 (HR,0.32;P < .001).
- 在BRCA1 (HR,0.28) 和BRCA2 (HR,0.43) 携带者中都注意到减少,75岁时累积死亡率大幅下降.
结论:
- 双边卵巢切除术与BRCA1或BRCA2序列变异的女性所有原因死亡率的显著降低有关.
- 这一发现支持预防性卵巢切除术在改善高风险个体的长期生存中的作用.
更多相关视频
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
12.3K
09:24Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
9.1K
相关概念视频
Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
